EPIRUS Biopharmaceuticals (Nasdaq:EPRS) is a pure-play biosimilar company focused on the global development and commercialization of biosimilar monoclonal antibodies (mAbs). EPIRUS' goal is to improve global patient access to important, cost-effective medicines. The company's current pipeline of biosimilar product candidates includes: BOW015 (infliximab, reference biologic Remicade®) currently marketed outside the U.S. and in an ongoing global Phase 3 study for registration in Europe and North America; BOW050 (adalimumab, reference biologic Humira®); BOW070 (tocilizumab, reference biologic Actemra®); BOW080 (eculizumab, reference biologic Soliris®); BOW090 (ustekinumab, reference biologic STELARA®); and BOW100 (golimumab, reference biologic SIMPONI®). The reference products for these candidates together generated approximately $29.2 billion in global sales for 2014, according to EvaluatePharma®. EPIRUS has established multiple partnerships to support its regulatory and commercialization efforts in global markets.
View Top Employees from EPIRUS BiopharmaceuticalsWebsite | http://www.epirusbiopharma.com |
Ticker | OTCPINK:EPRSQ |
Revenue | $701000 |
Employees | 7 (4 on RocketReach) |
Founded | 2013 |
Address | 699 Boylston St Fl 8, Boston, Massachusetts 02116, US |
Phone | (617) 600-3497 |
Technologies |
JavaScript,
HTML,
PHP
+23 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Life Science, Therapeutics, Health Care |
Web Rank | 17 Million |
Keywords | Epirus Biopharmaceuticals Inc |
Competitors | Abmaxis, Cormedix Inc., Eiger BioPharmaceuticals, Otonomy, Inc, Puma Biotechnology, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular EPIRUS Biopharmaceuticals employee's phone or email?
The EPIRUS Biopharmaceuticals annual revenue was $701000 in 2024.
Barbara Pritchard is the Senior Director of EPIRUS Biopharmaceuticals.
4 people are employed at EPIRUS Biopharmaceuticals.
EPIRUS Biopharmaceuticals is based in Boston, Massachusetts.
The NAICS codes for EPIRUS Biopharmaceuticals are [32, 32541, 325, 3254].
The SIC codes for EPIRUS Biopharmaceuticals are [283, 28].